• Home
  • News
  • Learn
    • What is PBM?
      • History of PBM
    • Patient Advice
      • Importance of Blood
      • What Your Doctor Should Tell You
      • Doctor/Patient Relationship
      • 3 Simple Questions To Ask Your Doctor
    • PBM for Health Professionals
      • How IFPBM Can Support You
      • Learn About PBM
      • Research
  • Resources
    • Articles
    • Videos
    • Textbooks
    • Guidelines
    • Conferences
    • Speakers
    • Links
  • About
    • Board of Trustees
      • Prof. Dr. Hans Gombotz
    • Scientific Associates
    • Contact Us
    • Network
    • Support / Collaborate
    • Donate
  • English
    • 简体中文 (Chinese (Simplified))
    • Português (Portuguese (Portugal))
    • Español (Spanish)
  • Home
  • News
  • Learn
    • What is PBM?
      • History of PBM
    • Patient Advice
      • Importance of Blood
      • What Your Doctor Should Tell You
      • Doctor/Patient Relationship
      • 3 Simple Questions To Ask Your Doctor
    • PBM for Health Professionals
      • How IFPBM Can Support You
      • Learn About PBM
      • Research
  • Resources
    • Articles
    • Videos
    • Textbooks
    • Guidelines
    • Conferences
    • Speakers
    • Links
  • About
    • Board of Trustees
      • Prof. Dr. Hans Gombotz
    • Scientific Associates
    • Contact Us
    • Network
    • Support / Collaborate
    • Donate
  • English
    • 简体中文 (Chinese (Simplified))
    • Português (Portuguese (Portugal))
    • Español (Spanish)
Log in

International Foundation for Patient Blood Management (IFPBM)

Articles

  • Anesthetic
    • Anesthetic management
    • Autotransfusion
      • Autologous cell salvage
      • Hemodilution
      • Preoperative autologous donation
    • Fluid management
  • Blood Conservation
  • Burn Management
  • Cardiology
  • Critical care
  • Donor Issues
  • Economics
  • Ethical Considerations
  • GI Hemorrhage
  • Gynecology / Obstetrics
  • Hematology / Oncology
  • Hemopoiesis
    • Anemia evaluation
    • Erythropoiesis-stimulating agents (ESAs)
      • Medical application
      • Surgical application
    • Hematinics
    • Iron
    • Other
    • Platelet stimulants
  • Hemostasis
    • Drugs
    • Evaluation / management
    • Interventional
    • Other (Hemostasis)
    • Surgical
    • Topical
  • Miscellaneous
  • Oxygen Therapeutics
  • PBM General
  • Pediatrics / Neonatology
  • Surgical
    • Cardiothoracic
    • Devices
    • General
    • Neurologic
    • Oral and Maxillofacial
    • Orthopedic
    • Otolaryngology
    • Plastic
    • Transplantation
    • Trauma Surgery
    • Urologic
    • Vascular
  • Transfusion Efficacy
  • Transfusion Risks / Hazards
    • Adverse outcomes
    • Immunomodulation
    • Infectious
    • Non-infectious
    • Other (Transfusion Risks and Hazards)
    • Storage lesion
  • Transfusion Safety
  • Transfusion triggers / practice
  • Trauma

Burn Management

Title

Date Published

Reducing postburn injury anemia in a Jehovah’s Witness patient

July 31, 2014

Peripheral blood mononuclear cell-derived erythroid progenitors and erythroblasts are decreased in burn patients.

January 1, 2013

Blood utilization in patients with burn injury and association with clinical outcomes.

December 24, 2012

Perioperative treatment algorithm for bleeding burn patients reduces allogeneic blood product requirements.

June 19, 2012

Red blood cell transfusion following burn.

March 1, 2011

Transfusions in Burn Patients With/Without Comorbidities.

January 21, 2009

Five percent albumin for adult burn shock resuscitation: lack of effect on daily multiple organ dysfunction score.

January 1, 2006

IFPBM is funded by your subscriptions & donations

Subscribe

Donate

Privacy Policy

Cookie Policy

IFPBM Terms & Conditions

© The International Foundation for Patient Blood Management
Images Copyright: 123RF Stock Photo
Custom Websites for Non-Profit Health Providers

  • Twitter
  • Instagram
  • Facebook
  • LinkedIn